The Cholinergic Deficit Coincides with Aβ Deposition at the Earliest Histopathologic Stages of Alzheimer Disease
Open Access
- 1 April 2000
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Neuropathology and Experimental Neurology
- Vol. 59 (4) , 308-313
- https://doi.org/10.1093/jnen/59.4.308
Abstract
Effective therapeutic intervention in Alzheimer disease (AD) will be most effective if it is directed at early events in the pathogenic sequence. The cholinergic deficit may be such an early event. In the present study, the brains of 26 subjects who had no history of cognitive loss and who were in early histopathologic stages of AD (average Braak stage less than II) were examined at autopsy to determine whether a cortical cholinergic decrement was associated with Aβ concentration or deposition. In the superior frontal and inferior temporal gyri, the choline acetyltransferase (ChAT) activity of plaque-containing cases was significantly decreased (p < 0.05, unpaired, two-tailed t-tests), measuring 70.9% and 79.5%, respectively, relative to plaque-free cases. In the inferior temporal gyrus, Spearman's rank correlation analysis showed that ChAT activity had a significant inverse correlation with Aβ concentration (p = 0.075; r = −0.3552). The results indicate that the cholinergic deficit is established at an early histopathologic stage of AD, before the onset of clinical symptoms.Keywords
This publication has 42 references indexed in Scilit:
- Elevated Low-Density Lipoprotein in Alzheimer's Disease Correlates with Brain Aβ 1–42 LevelsBiochemical and Biophysical Research Communications, 1998
- Effects of the M1 Agonist Xanomeline on Processing of Human β-Amyloid Precursor Protein (FAD, Swedish Mutant) Transfected into Chinese Hamster Ovary-m1 CellsBiochemical and Biophysical Research Communications, 1998
- Increased plasma amyloid β protein 1–42 levels in Down syndromeNeuroscience Letters, 1998
- Muscarinic m1 receptor agonists increase the secretion of the amyloid precursor protein ectodomainLife Sciences, 1997
- The muscarinic M1 agonist xanomeline increases soluble amyloid precursor protein release from chinese hamster ovary-m1 cellsLife Sciences, 1995
- Muscarinic Regulation of Alzheimer's Disease Amyloid Precursor Protein Secretion and Amyloid β-Protein Production in Human Neuronal NT2N CellsJournal of Biological Chemistry, 1995
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991
- Demonstration of Amyloid Deposits and Neurofibrillary Changes in Whole Brain SectionsBrain Pathology, 1991
- Oral Physostigmine as Treatment for Dementia of the Alzheimer TypeAlzheimer Disease & Associated Disorders, 1990
- SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASEPublished by Elsevier ,1976